Nemera is a world leader in the design, development and manufacturing of drug delivery devices for the pharmaceutical, biotechnology & generics industries. Nemera’s services and products cover several key delivery routes, providing standard and electronic features:
● Ophthalmic (multidose eyedroppers for preservative-free formulations),
● Nasal, buccal, auricular (pumps, valves and actuators for sprays),
● Inhalation (pMDIs, DPIs),
● Dermal and transdermal (airless & atmospheric dispensers),
● Parenteral (autoinjectors, pens, safety devices & implanters).
Nemera always puts patients first, providing the most comprehensive range of devices in the industry, including off-the-shelf innovative systems, customized design development and contract manufacturing.
Founded in 1896 in France and with a global footprint and a strong sales force, SGD Pharma is recognized worldwide as a key player that customers can rely on to support new product development, day-to-day delivery, quality or regulatory support. SGD Pharma benefits from a long know-how and a best-in-class manufacturing footprint. The company has a long-term investment plan to regularly leverage its manufacturing facilities and develop people competencies to be at the cutting edge of the technology. SGD Pharma commits to have the same standard in all its facilities. In 2020, all plants are certified according to ISO 15378 standard, pharma GMP’s compliant and equipped with ISO 8 clean rooms. SGD Pharma is the sole producer of molded glass for pharmaceutical primary packaging, operating worldwide with five factories and a network of more than 90 partners and distributors. For more information, please visit www.sgd-pharma.com